The article discusses treatment access for patients with schizophrenia and bipolar disorder. Patients who qualify for Medicare Part A are known as dual eligibles. They also are eligible for Medicare Part D, the prescription drug benefit associated with Medicare. The implications of the dual eligibility system is discussed.